NO20045496L - Anvendelse av nefopam for behandling av kvalme eller emesis - Google Patents

Anvendelse av nefopam for behandling av kvalme eller emesis

Info

Publication number
NO20045496L
NO20045496L NO20045496A NO20045496A NO20045496L NO 20045496 L NO20045496 L NO 20045496L NO 20045496 A NO20045496 A NO 20045496A NO 20045496 A NO20045496 A NO 20045496A NO 20045496 L NO20045496 L NO 20045496L
Authority
NO
Norway
Prior art keywords
nefopam
emesis
nausea
treatment
dizziness
Prior art date
Application number
NO20045496A
Other languages
English (en)
Norwegian (no)
Inventor
Robin Mark Bannister
Michael Harvey Lyne
Original Assignee
Arakis Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arakis Ltd filed Critical Arakis Ltd
Publication of NO20045496L publication Critical patent/NO20045496L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/5545—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having eight-membered rings not containing additional condensed or non-condensed nitrogen-containing 3-7 membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20045496A 2002-06-17 2004-12-16 Anvendelse av nefopam for behandling av kvalme eller emesis NO20045496L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0213869.1A GB0213869D0 (en) 2002-06-17 2002-06-17 The treatment of pain
PCT/GB2003/002586 WO2003105832A1 (fr) 2002-06-17 2003-06-17 Utilisation de nefopam pour traiter des nausees ou des vomissements

Publications (1)

Publication Number Publication Date
NO20045496L true NO20045496L (no) 2005-01-12

Family

ID=9938718

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20045496A NO20045496L (no) 2002-06-17 2004-12-16 Anvendelse av nefopam for behandling av kvalme eller emesis

Country Status (15)

Country Link
US (2) US20060040905A1 (fr)
EP (2) EP1513518A1 (fr)
JP (2) JP2005533784A (fr)
CN (1) CN100482221C (fr)
AU (2) AU2003240113B2 (fr)
BR (1) BR0311874A (fr)
CA (2) CA2489306A1 (fr)
GB (1) GB0213869D0 (fr)
IL (1) IL165773A0 (fr)
MX (1) MXPA04012826A (fr)
NO (1) NO20045496L (fr)
NZ (1) NZ537197A (fr)
PL (1) PL374418A1 (fr)
WO (2) WO2003105832A1 (fr)
ZA (1) ZA200410102B (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0330049D0 (en) * 2003-12-24 2004-02-04 Arakis Ltd The treatment of neuropathic pain conditions
GB0408864D0 (en) * 2004-04-21 2004-05-26 Arakis Ltd Novel benzoxazocines
GB0515703D0 (en) * 2005-07-29 2005-09-07 Arakis Ltd Therapeutic use of nefopam
WO2009002933A1 (fr) * 2007-06-22 2008-12-31 Hydra Biosciences, Inc. Procédés et compositions pour le traitement de troubles
GB0721013D0 (en) 2007-10-25 2007-12-05 Sosei R & D Ltd New Salts
PT2293794E (pt) 2008-05-27 2013-07-10 Univ Melbourne Métodos de tratamento de mamíferos com disfunções da trompa de eustáquio
US20110092493A1 (en) * 2008-09-24 2011-04-21 Clark Levi Dose-controlled transdermal promethazine compositions and methods of use
CN102458400B (zh) 2009-05-20 2014-10-08 国立健康与医学研究所 用于治疗病灶性前庭功能障碍的血清素5-ht3受体拮抗剂
US8957107B2 (en) * 2009-12-15 2015-02-17 The Hospital For Sick Children Method of treating scars and β-catenin-mediated disorders using Nefopam compounds
EP4335508A3 (fr) 2016-04-14 2024-07-10 Sensorion (+)-azasetron destiné à être utilisé dans le traitement de troubles de l'oreille
US10736905B1 (en) 2016-09-09 2020-08-11 Shahin Fatholahi Nefopam dosage forms and methods of treatment
US10736874B1 (en) 2017-09-08 2020-08-11 Shahin Fatholahi Methods for treating pain associated with sickle cell disease
US11446311B2 (en) 2017-09-08 2022-09-20 Shahin Fatholahi Methods for treating pain associated with sickle cell disease
RS65140B1 (sr) * 2019-05-06 2024-02-29 Chemcom Sa Upotreba kompozicije protiv neprijatnih mirisa i povezani postupak

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2234266T3 (es) * 1998-07-24 2005-06-16 Jago Research Ag Formulaciones medicas para aerosoles.
US20020013331A1 (en) * 2000-06-26 2002-01-31 Williams Robert O. Methods and compositions for treating pain of the mucous membrane

Also Published As

Publication number Publication date
NZ537197A (en) 2007-10-26
AU2003240113A1 (en) 2003-12-31
PL374418A1 (en) 2005-10-17
ZA200410102B (en) 2006-07-26
MXPA04012826A (es) 2005-03-31
JP2005531612A (ja) 2005-10-20
WO2003105833A1 (fr) 2003-12-24
JP2005533784A (ja) 2005-11-10
US20060040905A1 (en) 2006-02-23
IL165773A0 (en) 2006-01-15
AU2003277077A1 (en) 2003-12-31
CA2489306A1 (fr) 2003-12-24
EP1513517A1 (fr) 2005-03-16
AU2003277077B2 (en) 2006-11-02
CA2489315A1 (fr) 2003-12-24
EP1513518A1 (fr) 2005-03-16
CN1668294A (zh) 2005-09-14
GB0213869D0 (en) 2002-07-31
AU2003240113B2 (en) 2006-11-16
BR0311874A (pt) 2005-05-10
CN100482221C (zh) 2009-04-29
US20060063753A1 (en) 2006-03-23
WO2003105832A1 (fr) 2003-12-24

Similar Documents

Publication Publication Date Title
NO20045496L (no) Anvendelse av nefopam for behandling av kvalme eller emesis
RS20060320A (en) Substituted indazole-o-glucosides
MY142777A (en) Substituted indole-o-glucosides
UA87991C2 (en) Substituted indole-o-glucosides
AU2003220970A1 (en) Diamino-pyrimidines and their use as angiogenesis inhibitors
DK1343782T3 (da) Pyrimidinaminer som angiogenesemodulatorer
WO2005012242A3 (fr) Benzimidazole-, benztriazole- et benzimidazolone-o-glucosides substitues
WO2005058537A3 (fr) Dispositifs medicaux et leurs procedes de fabrication
WO2005012318A3 (fr) C-glycosides heterocycliques fusionnes substitues
CY1108067T1 (el) Υποκατεστημενα παραγωγα 2-πυριδινο-κυκλοεξανο-1,4-διαμινης
CL2004001174A1 (es) Composicion farmaceutica que comprende: 1-(4-fluorofenil)-3(r)-[3-(4-fluorofenil)-3(s)-hidroxipropil]-4(s)-(4-hidroxifenil)-2-acetidinona (ezetimiba) y excipientes; y su uso en el tratamiento y/o prevencion de aterosclerosis, hipercolesterolemia, dia
WO2006100081A3 (fr) Derives d'indoxyle substitues, medicaments les contenant et leur utilisation
IL171974A0 (en) Tetrahydrocarbazole derivatives and their pharmaceutical use
CY1110664T1 (el) Ενδορινικες συνθεσετς
BRPI0607351A2 (pt) métodos para tratamento de linfomas empregando uma combinação de agente quimioterapêutico e il-2 e opcionalmente um anticorpo anti-cd20
NO20054535L (no) Bifunksjonelle heterocykliske forbindelser og fremgangsmater for fremstilling og anvendelse av samme
IL165790A0 (en) Cationically substituted diphenyl azetidinones method for their production medicaments containing said compounds and use thereof
TW200504402A (en) Antimicrobial lenses, processes to prepare them and methods of their use
MY149864A (en) Flavouring-containing pharmaceutical formulations with improved pharmaceutical properties
MXPA04004090A (es) Compuestos substituidos de 1h-quinolin-2-ona.
UA85187C2 (en) 2-aminobenzoyl derivatives
EP1436279A4 (fr) Composes chimiques
WO2004058353A3 (fr) Utilisation therapeutique d'inhibiteurs selectifs de recaptage de noradrenaline
RS20060323A (en) Substituted indole-o-glucosides
RS20050038A (en) Stabilization of the profile of release of active substances from a formulation

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application